Frost & Sullivan explores the emerging potential of the controversial multi-billion dollar stem cell and regenerative medicine industries at the 2014 World Stem Cell Summit

MOUNTAIN VIEW, CA – November 11, 2014 – Frost & Sullivan is participating in a panel entitled “Regenerative Medicine & Cell Therapy – Multi-Billion Industries with Unlimited Potential” at the 2014 World Stem Cell Summit at the Marriott Rivercenter San Antonio, Texas from 9:30 to 10:30 a.m. CST on Wednesday, Dec. 3, 2014.

The three panelists are Jane C. Andrews, Ph.D., Frost & Sullivan; Gregory A. Bonfiglio, Proteus Venture Partners and Chris Mason, MBBS, Ph.D., FRCS, University College London.

Multi-billion dollar companies and small start-ups alike are investing their dollars in the emerging multi-billion dollar regenerative medicine market.  There are more clinical trials utilizing stem cells than ever before, especially in the areas of nerve regeneration, cancer treatment, drug therapy and diabetes.  The industry is young, expanding rapidly and will take us into a new age of medicine.

This panel will discuss the leading industry trends, highlight current successes and discuss the future of stem cell regenerative medicine. It will also feature presentations on the global capital market and the scientific underpinnings of this cutting-edge and transformative field.

“When it comes to discovering what stem cells can do, we’re currently only at the tip of the iceberg,” said Frost & Sullivan Healthcare & Life Sciences Senior Consultant Jane Andrews. “It is astounding what new research is proving and the interest it is generating. So much so in fact, I believe we’re entering a new age of medicine where regeneration of cells and tissues will become routine.”

“With the convergence of innovative technologies, the regenerative medicine industry is entering a phase of explosive growth,” said World Stem Cell Summit Founder and Genetics Policy Institute Executive Director Bernard Siegel. “The era of treating formerly incurable medical conditions with stem cell therapies and the use of cells to advance new drug discovery represents the future of medicine. It will impact humanity profoundly. What the Industrial Revolution was to the 19th Century the “Regenerative Medicine Revolution” will be to our 21st Century.”

“The Frost & Sullivan panel at the RegMed Capital Conference is the foundational session of the meeting. It will provide context to all stakeholders for understanding the magnitude of the financial opportunities at the acceleration nexus point of this burgeoning field.”

Attend this panel by registering for the 2014 World Stem Cell Summit via: Frost & Sullivan clients have access to discounted registration to the RegMed Capital Conference, co-located at the World Stem Cell Summit. Contact Jennifer Carson ( for more information and discounted registration details.

For more information about Frost & Sullivan’s global Healthcare practice, pleasevisit:

About World Stem Cell Summit

The World Stem Cell Summit, produced by the Genetics Policy Institute (GPI), is the largest interdisciplinary, networking meeting of stem cell science and regenerative medicine stakeholders, uniting the diverse community. With the overarching purpose of fostering biomedical research, funding and investments targeting cures, the Summit is the single conference charting the future of this burgeoning field.

The program provides the research, industry, economic and societal context for understanding how all of the pieces of the stem cell science and regenerative medicine puzzle fit together. Supported by 200 organizing partners, sponsors, exhibitors, endorsing organizations and media partners, the Summit is a three-day showcase of innovation, insight and inspiration.

About Frost & Sullivan 

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants. For more than 50 years, we have been developing growth strategies for the Global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies? Contact us: Start the discussion (